Perenterol Lyo-Sol, polvere per sospensione orale

7680685590015 CH-68559 sospensione

Associated product:

PERENTEROL Lyo-Sol pdr p susp fl 10 pce
Perenterol Lyo-Sol, polvere per sospensione orale
Perenterol Lyo-Sol, polvere per sospensione orale
Perenterol Lyo-Sol, polvere per sospensione orale
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Flasche(n)
Galenic form
sospensione
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/03/2025
Patient information leaflet
Français
27/03/2025
Patient information leaflet
Italien
27/03/2025
Summary of Product Characteristics
Allemand
27/03/2025
Summary of Product Characteristics
Français
27/03/2025
Summary of Product Characteristics
Italien
27/03/2025

Detailed composition

Substance Quantity Type Category
PUL
250.0 MG Substance Wirkstoff (Principe actif)
SOLU
1520.0 MG Substance HBESI
SOLU
- Substance HNIDK
PUL
- Substance WIIS
SOLU
- Substance AROMA
PUL
32.5 MG Substance HBESI
SOLU
10.08 MG Substance HBESI
SOLU
1.2 MG Substance HBESI
SOLU
4.48 MG Substance HBESI
SOLU
- Substance HNIDK
SOLU
8.0 MG Substance HBESI
SOLU
1.272 MG Substance HBESI
SOLU
- Substance HNIDK

Authorization holder

Zambon Svizzera SA

6814 Cadempino

Authorization information

Swissmedic authorization number
68559
Drug name
Perenterol Lyo-Sol, polvere per sospensione orale
Galenic form
LYLSU
ATC Code
A07FA02
Authorization status
Z
Dispensing category
D
First authorization
16/05/2023
Authorization expiration date
15/05/2028
IT Number
04.09.0.
Domain
Human medicine
Field of application
Zur symptomatischen Behandlung von Durchfallerkrankungen verschiedener Genese

Package details

Description (FR)
PERENTEROL Lyo-Sol pdr p susp fl 10 pce
Description (DE)
PERENTEROL Lyo-Sol Plv f Susp Fl 10 Stk
Market launch
16/05/2023
Narcotic (BTM)
No

Other package sizes (1)

None
14 FLAS
GTIN: None
Not in V1